Doximity Research Development vs Income Tax Expense Analysis

DOCS Stock

USD 53.28 1.14 2.19%

Doximity financial indicator trend analysis is much more than just examining Doximity latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Doximity is a good investment. Please check the relationship between Doximity Research Development and its Income Tax Expense accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Doximity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Doximity Stock please use our How to Invest in Doximity guide.

Research Development vs Income Tax Expense

Research Development vs Income Tax Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Doximity Research Development account and Income Tax Expense. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Doximity's Research Development and Income Tax Expense is 0.44. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of Doximity, assuming nothing else is changed. The correlation between historical values of Doximity's Research Development and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Doximity are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Research Development i.e., Doximity's Research Development and Income Tax Expense go up and down completely randomly.

Correlation Coefficient

0.44

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Research Development

Income Tax Expense

Most indicators from Doximity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Doximity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Doximity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Doximity Stock please use our How to Invest in Doximity guide.At this time, Doximity's Tax Provision is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 8 B in 2024, whereas Selling General Administrative is likely to drop slightly above 26 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Income	2.1M	9.3M	21.7M	22.7M
Net Interest Income	2.1M	9.3M	21.7M	22.7M

Interest Income Net Interest Income

Doximity fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment
Total Assets		-0.36	0.94	0.99	0.79	0.95	0.92	-0.94	0.94	0.41	0.95	0.97	0.74	0.95	1.0	0.98	0.92	1.0	-0.45	0.84	0.94	0.75	1.0	0.9	0.99	0.86
Other Current Liab	-0.36		-0.53	-0.27	-0.23	-0.34	-0.47	0.45	-0.45	-0.45	-0.44	-0.38	-0.85	-0.37	-0.34	-0.46	-0.47	-0.32	0.06	-0.37	-0.27	-0.8	-0.36	-0.32	-0.49	-0.43
Total Current Liabilities	0.94	-0.53		0.9	0.81	0.9	0.96	-0.91	0.9	0.6	0.93	0.97	0.87	0.9	0.92	0.99	0.93	0.91	-0.49	0.88	0.86	0.91	0.93	0.93	0.96	0.9
Total Stockholder Equity	0.99	-0.27	0.9		0.77	0.94	0.88	-0.92	0.93	0.33	0.93	0.95	0.67	0.94	1.0	0.96	0.88	1.0	-0.43	0.81	0.94	0.67	1.0	0.88	0.97	0.82
Other Liab	0.79	-0.23	0.81	0.77		0.87	0.88	-0.7	0.65	0.69	0.75	0.87	0.54	0.87	0.76	0.82	0.93	0.75	-0.78	0.92	0.87	0.69	0.77	0.88	0.76	0.97
Net Tangible Assets	0.95	-0.34	0.9	0.94	0.87		0.87	-0.87	0.87	0.43	0.89	0.92	0.71	1.0	0.95	0.93	0.94	0.95	-0.64	0.94	0.99	0.72	0.95	0.84	0.95	0.92
Property Plant And Equipment Net	0.92	-0.47	0.96	0.88	0.88	0.87		-0.87	0.83	0.69	0.9	0.98	0.76	0.87	0.89	0.96	0.95	0.88	-0.52	0.84	0.85	0.87	0.9	0.98	0.91	0.93
Net Debt	-0.94	0.45	-0.91	-0.92	-0.7	-0.87	-0.87		-0.99	-0.27	-1.0	-0.9	-0.8	-0.87	-0.94	-0.94	-0.9	-0.93	0.22	-0.72	-0.86	-0.77	-0.94	-0.86	-0.95	-0.79
Retained Earnings	0.94	-0.45	0.9	0.93	0.65	0.87	0.83	-0.99		0.21	0.98	0.88	0.8	0.87	0.95	0.93	0.87	0.94	-0.19	0.71	0.85	0.75	0.95	0.82	0.96	0.75
Accounts Payable	0.41	-0.45	0.6	0.33	0.69	0.43	0.69	-0.27	0.21		0.33	0.59	0.49	0.44	0.34	0.52	0.57	0.34	-0.68	0.64	0.39	0.71	0.37	0.64	0.42	0.7
Cash	0.95	-0.44	0.93	0.93	0.75	0.89	0.9	-1.0	0.98	0.33		0.93	0.79	0.89	0.95	0.96	0.93	0.93	-0.27	0.75	0.87	0.79	0.95	0.9	0.96	0.83
Non Current Assets Total	0.97	-0.38	0.97	0.95	0.87	0.92	0.98	-0.9	0.88	0.59	0.93		0.74	0.92	0.95	0.99	0.94	0.95	-0.52	0.86	0.91	0.81	0.96	0.97	0.95	0.91
Non Currrent Assets Other	0.74	-0.85	0.87	0.67	0.54	0.71	0.76	-0.8	0.8	0.49	0.79	0.74		0.72	0.72	0.82	0.77	0.71	-0.25	0.69	0.64	0.95	0.74	0.68	0.83	0.72
Other Assets	0.95	-0.37	0.9	0.94	0.87	1.0	0.87	-0.87	0.87	0.44	0.89	0.92	0.72		0.94	0.93	0.95	0.94	-0.64	0.94	0.99	0.73	0.95	0.84	0.95	0.93
Cash And Short Term Investments	1.0	-0.34	0.92	1.0	0.76	0.95	0.89	-0.94	0.95	0.34	0.95	0.95	0.72	0.94		0.97	0.9	1.0	-0.41	0.81	0.94	0.71	1.0	0.87	0.99	0.83
Net Receivables	0.98	-0.46	0.99	0.96	0.82	0.93	0.96	-0.94	0.93	0.52	0.96	0.99	0.82	0.93	0.97		0.95	0.96	-0.46	0.86	0.91	0.85	0.98	0.94	0.98	0.9
Common Stock Shares Outstanding	0.92	-0.47	0.93	0.88	0.93	0.94	0.95	-0.9	0.87	0.57	0.93	0.94	0.77	0.95	0.9	0.95		0.89	-0.58	0.91	0.93	0.84	0.91	0.92	0.92	0.98
Short Term Investments	1.0	-0.32	0.91	1.0	0.75	0.95	0.88	-0.93	0.94	0.34	0.93	0.95	0.71	0.94	1.0	0.96	0.89		-0.43	0.82	0.94	0.69	1.0	0.86	0.98	0.82
Inventory	-0.45	0.06	-0.49	-0.43	-0.78	-0.64	-0.52	0.22	-0.19	-0.68	-0.27	-0.52	-0.25	-0.64	-0.41	-0.46	-0.58	-0.43		-0.82	-0.64	-0.4	-0.43	-0.48	-0.42	-0.73
Other Current Assets	0.84	-0.37	0.88	0.81	0.92	0.94	0.84	-0.72	0.71	0.64	0.75	0.86	0.69	0.94	0.81	0.86	0.91	0.82	-0.82		0.92	0.76	0.83	0.81	0.84	0.96
Other Stockholder Equity	0.94	-0.27	0.86	0.94	0.87	0.99	0.85	-0.86	0.85	0.39	0.87	0.91	0.64	0.99	0.94	0.91	0.93	0.94	-0.64	0.92		0.66	0.94	0.83	0.93	0.91
Total Liab	0.75	-0.8	0.91	0.67	0.69	0.72	0.87	-0.77	0.75	0.71	0.79	0.81	0.95	0.73	0.71	0.85	0.84	0.69	-0.4	0.76	0.66		0.73	0.8	0.81	0.83
Total Current Assets	1.0	-0.36	0.93	1.0	0.77	0.95	0.9	-0.94	0.95	0.37	0.95	0.96	0.74	0.95	1.0	0.98	0.91	1.0	-0.43	0.83	0.94	0.73		0.89	0.99	0.84
Intangible Assets	0.9	-0.32	0.93	0.88	0.88	0.84	0.98	-0.86	0.82	0.64	0.9	0.97	0.68	0.84	0.87	0.94	0.92	0.86	-0.48	0.81	0.83	0.8	0.89		0.88	0.9
Common Stock	0.99	-0.49	0.96	0.97	0.76	0.95	0.91	-0.95	0.96	0.42	0.96	0.95	0.83	0.95	0.99	0.98	0.92	0.98	-0.42	0.84	0.93	0.81	0.99	0.88		0.86
Property Plant Equipment	0.86	-0.43	0.9	0.82	0.97	0.92	0.93	-0.79	0.75	0.7	0.83	0.91	0.72	0.93	0.83	0.9	0.98	0.82	-0.73	0.96	0.91	0.83	0.84	0.9	0.86

Click cells to compare fundamentals

Doximity Account Relationship Matchups

Doximity fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	138.9M	251.7M	991.4M	1.1B	1.1B	675.6M
Other Current Liab	8.0M	15.9M	23.8M	28.0M	27.5M	25.7M
Total Current Liabilities	55.7M	102.0M	111.3M	139.5M	147.3M	108.8M
Total Stockholder Equity	1.1M	66.7M	878.6M	966.1M	901.4M	524.8M
Other Liab	288K	1.2M	1.0M	17.4M	20.0M	21.0M
Property Plant And Equipment Net	7.1M	8.9M	9.6M	25.1M	24.7M	14.1M
Net Debt	(46.1M)	(65.1M)	(111.7M)	(142.4M)	(82.2M)	(86.4M)
Retained Earnings	(13.9M)	36.3M	191.1M	217.9M	80.0M	85.8M
Accounts Payable	1.4M	1.5M	463K	1.3M	2.3M	1.4M
Cash	48.4M	66.4M	112.8M	158.0M	96.8M	94.6M
Non Current Assets Total	15.9M	42.3M	87.2M	161.4M	166.4M	87.1M
Non Currrent Assets Other	1.3M	2.8M	2.3M	1.7M	1.5M	1.4M
Cash And Short Term Investments	86.4M	142.5M	798.1M	841.0M	762.9M	493.8M
Net Receivables	26.2M	50.3M	81.1M	107.0M	101.3M	69.9M
Short Term Investments	38.0M	76.1M	685.3M	683.0M	666.1M	399.2M
Other Current Assets	6.9M	16.5M	25.0M	27.4M	48.7M	51.1M
Other Stockholder Equity	15.0M	(81.5M)	702.6M	762.2M	823.9M	865.1M
Total Liab	137.8M	185.0M	112.8M	170.8M	178.0M	150.7M
Total Current Assets	123.0M	209.4M	904.1M	975.5M	912.9M	588.2M
Intangible Assets	393K	9.6M	7.9M	31.8M	27.3M	14.2M
Common Stock	68K	83K	192K	194K	187K	138.8K
Property Plant Equipment	7.1M	8.9M	9.6M	25.1M	28.9M	30.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Doximity Stock Analysis

When running Doximity's price analysis, check to measure Doximity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Doximity is operating at the current time. Most of Doximity's value examination focuses on studying past and present price action to predict the probability of Doximity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Doximity's price. Additionally, you may evaluate how the addition of Doximity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC